Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

The Cambridge, Massachusetts-based biotech conducted a ... according to Schwartz. Merck bets up to $1B on Pearl's 'smart' biomaterial jewels as biotech begins to raise fresh funds However, this ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Halozyme Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, ...

The open-label MK-8591A-051 (NCT05631093) trial and the double-blind MK-8591A-052 (NCT05630755) trial, both from Merck ... which operates the Massachusetts AIDS Drug Assistance Program, the ...

Merck is a global pharmaceutical giant ... including grid and energy management upgrades in Massachusetts and from the Greater Cambridge Energy Project. The latter is a $1.8 billion investment ...

GSK said it is paying $2.1 billion upfront for Cambridge, Massachusetts-based Affinivax ... That rise came despite the approval of Merck & Co's 15-valent Vaxneuvance in July 2021, which has ...

Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.

The Merck layoffs primarily impact its diabetes group in China ... Thermo Fisher Scientific will lay off 160 employees across locations in Lexington, Plainville and Cambridge, MA between January 6, ...